These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 1758382

  • 1. [Effect of pre-treatment with pyridostigmine on the stimulation of growth hormone by clonidine and GRF].
    Farello G, De Simone M, Gentile T, de Matteis F.
    Minerva Pediatr; 1991 Oct; 43(10):617-20. PubMed ID: 1758382
    [Abstract] [Full Text] [Related]

  • 2. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J, Diaz MJ, Tresguerres JA, Arce V, Lima L.
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [Abstract] [Full Text] [Related]

  • 3. Comparison of growth hormone-releasing effect of growth hormone-releasing hormone, clonidine and pyridostigmine in normal children and adolescents. GH-releasing effect of GHRH, clonidine and pyridostigmine.
    Ghigo E, Arvat E, Nicolosi M, Mazza E, Camanni F.
    Panminerva Med; 1990 Aug; 32(1):1-3. PubMed ID: 2263395
    [Abstract] [Full Text] [Related]

  • 4. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S, Ling SY, Leidy JW, Blaine K, Holtzman T.
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [Abstract] [Full Text] [Related]

  • 5. Differences in reproducibility and peak growth hormone responses to repeated testing with various stimulators in healthy adults.
    Hoeck HC, Jakobsen PE, Vestergaard P, Falhof J, Laurberg P.
    Growth Horm IGF Res; 1999 Feb; 9(1):18-24. PubMed ID: 10207504
    [Abstract] [Full Text] [Related]

  • 6. Effect of growth hormone-releasing factor on growth hormone release in children with radiation-induced growth hormone deficiency.
    Lustig RH, Schriock EA, Kaplan SL, Grumbach MM.
    Pediatrics; 1985 Aug; 76(2):274-9. PubMed ID: 3927254
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone secretion in aging. Effect of pyridostigmine on growth hormone responsiveness to growth hormone-releasing hormone.
    Giusti M, Marini G, Sessarego P, Peluffo F, Valenti S, Caratti C, Giordano G.
    Recenti Prog Med; 1991 Dec; 82(12):665-8. PubMed ID: 1815302
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the potentiating effect of pyridostigmine, arginine and propranolol on the GHRH-induced GH release in short children.
    Bellone J, Ghigo E, Procopio M, Arvat E, Valente F, Boffano GM, Maccario M, Dentelli P, Camanni F.
    Panminerva Med; 1993 Mar; 35(1):1-4. PubMed ID: 8316397
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.
    Guzzaloni G, Grugni G, Morabito F.
    Minerva Endocrinol; 1998 Dec; 23(4):99-104. PubMed ID: 10361807
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone response to GRF 1-44 in children following cranial irradiation for central nervous system tumors.
    Oberfield SE, Kirkland JL, Frantz A, Allen JC, Levine LS.
    Am J Pediatr Hematol Oncol; 1987 Dec; 9(3):233-8. PubMed ID: 3118729
    [Abstract] [Full Text] [Related]

  • 11. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
    Procopio M, Maccario M, Savio P, Valetto MR, Aimaretti G, Grottoli S, Oleandri SE, Baffoni C, Tassone F, Arvat E, Camanni F, Ghigo E.
    Minerva Endocrinol; 1999 Dec; 24(3-4):107-11. PubMed ID: 10953725
    [Abstract] [Full Text] [Related]

  • 12. [The predictive value of the GRF-stimulation test].
    Andler W, Eiden S.
    Klin Padiatr; 1990 Dec; 202(3):157-60. PubMed ID: 2113150
    [Abstract] [Full Text] [Related]

  • 13. Adrenergic and cholinergic involvement in basal and growth hormone-releasing hormone-stimulated growth hormone secretion in glucocorticoid-treated rats.
    Giustina A, Misitano V, Voltz D, Piering A, Wehrenberg WB.
    Endocr Res; 1995 Nov; 21(4):719-32. PubMed ID: 8582323
    [Abstract] [Full Text] [Related]

  • 14. Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man.
    Massara F, Ghigo E, Molinatti P, Mazza E, Locatelli V, Müller EE, Camanni F.
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):12-6. PubMed ID: 3020850
    [Abstract] [Full Text] [Related]

  • 15. Acute administration of pyridostigmine and clonidine has an additive stimulatory effect on GH release in normal children.
    Ghigo E, Goffi S, Mazza E, Imperiale E, Arvat E, Bellone J, Procopio M, Müller EE, Camanni F.
    J Endocrinol Invest; 1989 Feb; 12(2):99-101. PubMed ID: 2754188
    [Abstract] [Full Text] [Related]

  • 16. Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Pathophysiological, diagnostic and therapeutic implications.
    Müller EE, Locatelli V, Ghigo E, Cella SG, Loche S, Pintor C, Camanni F.
    Drugs; 1991 Feb; 41(2):161-77. PubMed ID: 1709847
    [Abstract] [Full Text] [Related]

  • 17. Impairment of growth hormone responsiveness to growth hormone releasing hormone and pyridostigmine in patients affected by Prader-Labhardt-Willi syndrome.
    Beccaria L, Benzi F, Sanzari A, Bosio L, Brambilla P, Chiumello G.
    J Endocrinol Invest; 1996 Nov; 19(10):687-92. PubMed ID: 9007701
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls.
    Tancer ME, Stein MB, Uhde TW.
    Psychoneuroendocrinology; 1990 Nov; 15(4):253-9. PubMed ID: 2087535
    [Abstract] [Full Text] [Related]

  • 19. Effect of the enhancement of the cholinergic tone by pyridostigmine on the exercise-induced growth hormone release in man.
    Cappa M, Grossi A, Benedetti S, Drago F, Loche S, Ghigo E.
    J Endocrinol Invest; 1993 Jun; 16(6):421-4. PubMed ID: 8370917
    [Abstract] [Full Text] [Related]

  • 20. Change in the growth hormone (GH) response to GH-releasing factor (GRF) caused by exogenous GH in short children.
    Tanaka T, Yano H, Umezawa S, Ohmae Y, Hashimoto N, Miki Y, Kagawa J, Tanae A, Hibi I.
    Endocrinol Jpn; 1990 Apr; 37(2):239-45. PubMed ID: 2226343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.